Protox(TM) Therapeutics Inc. (TSX-V:PRX) announced today that Lions Liquidity Investment Fund has become a new institutional investor. The fund, which is managed by Protox Chairman Frank Holler, is purchasing 1,000,000 common shares of the company by way of a private transaction with Dr. Tom Buckley, Chief Scientific Officer and founder of Protox. Dr. Buckley, who will be retiring from the company next year, is divesting the shares for the purposes of estate planning. Post transaction he will hold 2,780,000 shares and will remain fully committed to his role as head of research until his planned retirement.
